RBA Wealth Management
BSX icon

RBA Wealth Management’s Boston Scientific BSX Stock Holding History

RBA Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-71,213
Closed -$3.04M – 121
2026
Q2 		$3.04M Buy
71,213
+7,476
+12% +$406K 1.12% 43
2026
Q1 		$4M Buy
63,737
+1,368
+2% +$109K 1.44% 36
2025
Q4 		$5.95M Buy
62,369
+198
+0.3% +$19.4K 2.01% 17
2025
Q3 		$6.07M Sell
62,171
-1,137
-2% -$118K 2.09% 17
2025
Q2 		$6.8M Sell
63,308
-3,512
-5% -$355K 2.53% 9
2025
Q1 		$6.74M Sell
66,820
-583
-0.9% -$58.7K 2.67% 7
2024
Q4 		$6.02M Sell
67,403
-1,053
-2% -$92.7K 2.29% 10
2024
Q3 		$5.74M Buy
68,456
+1,210
+2% +$95.4K 2.21% 14
2024
Q2 		$5.18M Sell
67,246
-2,217
-3% -$162K 2.08% 18
2024
Q1 		$4.76M Sell
69,463
-1,220
-2% -$78.4K 1.93% 23
2023
Q4 		$4.09M Sell
70,683
-371
-0.5% -$19.8K 1.78% 29
2023
Q3 		$3.75M Buy
71,054
+936
+1% +$49.1K 1.81% 26
2023
Q2 		$3.79M Buy
70,118
+685
+1% +$35.8K 1.77% 28
2023
Q1 		$3.47M Buy
69,433
+2,302
+3% +$108K 1.73% 32
2022
Q4 		$3.11M Buy
67,131
+2,521
+4% +$109K 1.63% 32
2022
Q3 		$2.5M Buy
64,610
+923
+1% +$37K 1.44% 38
2022
Q2 		$2.37M Buy
63,687
+2,541
+4% +$103K 1.32% 39
2022
Q1 		$2.71M Buy
61,146
+5,950
+11% +$258K 1.3% 38
2021
Q4 		$2.34M Buy
55,196
+9,537
+21% +$401K 1.11% 42
2021
Q3 		$1.98M Buy
45,659
+1,696
+4% +$75K 4.78% 9
2021
Q2 		$1.88M Buy
43,963
+995
+2% +$41.9K 3.99% 10
2021
Q1 		$1.66M Buy
42,968
+3,128
+8% +$118K 1.41% 30
2020
Q4 		$1.43M Buy
39,840
+5,996
+18% +$216K 0.86% 50
2020
Q3 		$1.29M Buy
33,844
+3,971
+13% +$153K 0.87% 49
2020
Q2 		$1.05M Buy
29,873
+3,719
+14% +$134K 0.76% 49
2020
Q1 		$853K Buy
26,154
+10,377
+66% +$405K 0.74% 48
2019
Q4 		$712K Buy
15,777
+3,411
+28% +$143K 0.49% 52
2019
Q3 		$503K Buy
12,366
+6,520
+112% +$276K 0.38% 56
2019
Q2 		$251K Buy
+5,846
New +$225K 0.19% 75

Other funds holding BSX

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

RBA Wealth Management's BSX Position: Q3 2026 in Review

RBA Wealth Management sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 71,213 shares — an estimated $3.04M sold.

RBA Wealth Management first reported a position in BSX in Q2 2019 and held it in 29 quarters. The position peaked at $6.8M in Q2 2025. 1,076 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • RBA Wealth Management reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
  • RBA Wealth Management sold 71,213 Boston Scientific shares in Q3 2026, an estimated $3.04M.
  • RBA Wealth Management first reported a position in Boston Scientific in Q2 2019 and held it in 29 quarters.
  • RBA Wealth Management's Boston Scientific position peaked at $6.8M in Q2 2025.
  • 1,076 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on RBA Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.